Informazioni sul prodotto
- (3aS,8aR)-1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo[2,3-b]indol-5-yl methylcarbamate salicylate
- Benzoic acid
- 2-hydroxy-
- compd. with (3aS,8aR)-1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo[2,3-b]indol-5-yl methylcarbamate (1:1) (9CI)
- Benzoic acid
- 2-hydroxy-
- compd. with (3aS-cis)-1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo[2,3-b]indol-5-yl methylcarbamate (1:1)
- Physostigmine salicylate (6CI)
- Physostigmine
- monosalicylate (8CI)
- Vedi altri sinonimi
- Pyrrolo[2,3-b]indol-5-ol
- 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-
- methylcarbamate (ester)
- (3aS,8aR)-
- mono(2-hydroxybenzoate) (salt) (9CI)
- Pyrrolo[2,3-b]indol-5-ol
- 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-
- methylcarbamate (ester)
- (3aS-cis)-
- mono(2-hydroxybenzoate) (salt)
- Salicylic acid
- compd. with physostigmine (1:1) (8CI)
- Eserine salicylate
- Isopto Eserine
- (3aS,8aR)-1,3a,8-trimethyl-5-[(methylcarbamoyl)oxy]-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indolediium 2-oxidobenzoate
- 2-hydroxybenzoic acid - (3aS)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl methylcarbamate (1:1)
- Benzoic acid, 2-hydroxy-, compd. with (3aS,8aR)-1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo[2,3-b]indol-5-yl N-methylcarbamate (1:1)
- Benzoic acid, 2-hydroxy-, compd. with (3aS,8aR)-1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo[2,3-b]indol-5-yl methylcarbamate (1:1)
- Benzoic acid, 2-hydroxy-, compd. with (3aS-cis)-1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo[2,3-b]indol-5-yl methylcarbamate (1:1)
- Eserine salicylate salt
- Physostigmine salicylate
- Physostigmine, monosalicylate
- Pyrrolo[2,3-b]indol-5-ol, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-, methylcarbamate (ester), (3aS,8aR)-, mono(2-hydroxybenzoate) (salt)
- Pyrrolo[2,3-b]indol-5-ol, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-, methylcarbamate (ester), (3aS-cis)-, mono(2-hydroxybenzoate) (salt)
- Salicylic acid, compd. with physostigmine (1:1)
Applications Physostigmine Salicylate is a cholinesterase inhibitor with the potential to improve cognitive ability in individuals with alzheimers. In addition, as a parasympathomimetic, it is used to treat glaucoma, dry mouth, and delayed gastric emptying.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Thal, L. et al.: Neurol., 47, 1389 (1996); Hedner, E. et al.: Eur. J. Oral Sci., 109, 374 (2001);
Proprietà chimiche
Richiesta tecnica su: TR-P398510 Physostigmine Salicylate
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.